Hyperglycemia during the Immediate Period after Kidney Transplantation
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND OBJECTIVES: Hyperglycemia and new-onset diabetes occurs frequently after kidney transplantation. The stress of surgery and exposure to immunosuppression medications have metabolic effects and can cause or worsen preexisting hyperglycemia. To our knowledge, hyperglycemia in the immediate posttransplantation period has not been studied. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted a retrospective, observational study to characterize the prevalence and assess the pharmacologic management of hyperglycemia in kidney transplant recipients who underwent transplantation at our center between June 1999 and December 2006. Data were abstracted from electronic and pharmacy databases. RESULTS: The study cohort included 424 patients (mean age 51 yr; 58% men; 25% with pretransplantation diabetes). All patients with and 87% without pretransplantation diabetes had evidence of hyperglycemia (bedside glucose >or=200 mg/dl or physician-instituted insulin therapy), whereas the prevalence of hypoglycemia was low (4.5%). Hyperglycemia was sustained throughout hospitalization. All patients with and 66% without pretransplantation diabetes required insulin at hospital discharge. Patients with pretransplantation diabetes were treated primarily with short-acting insulin during the first 24 h after transplantation but were transitioned to long-acting insulin as the hospital stay progressed. CONCLUSIONS: Investigators have historically attempted to identify hyperglycemia after hospital discharge. Our data indicate that a substantial number of patients without pretransplantation diabetes develop hyperglycemia and require insulin during the hospital phase of their care immediately after kidney transplantation. Prospective studies are needed to delineate factors that contribute to development of new-onset diabetes after transplantation among patients with transient hyperglycemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In most cases, such stressor steroidinduced hyperglycemia resolves by the time of discharge (142,143).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [143]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Whereas posttransplantation hyperglycemia is an important risk factor for subsequent PTDM, a formal diagnosis of PTDM is optimally made once the individual is stable on maintenance immunosuppression (usually at least 45 days after transplantation) and in the absence of acute infection (138,142 -144,147).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [143]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Whereas posttransplantation hyperglycemia is an important risk factor for subsequent PTDM, a formal diagnosis of PTDM is optimally made once the individual is stable on maintenance immunosuppression (usually at least 45 days) and in the absence of acute infection (138,(142)(143)(144)147).”
From 2. Diagnosis and classification of diabetes: standards of care in diabetes-2025 (2025) · cites this paper as [143]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Diabetes Mellitus after Kidney Transplantation in the United States
Kasiske, B. L., Snyder, J. J., Gilbertson, D., & Matas, A. J. (2003) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2003.00010.x · Cited by 1,285
Management of diabetes and hyperglycemia in hospitals.
Clement, S., Braithwaite, S. S., Magee, M. F., Ahmann, A., Smith, E. P., Schafer, R. G., Hirsch, I. B., & on behalf of the Diabetes in Hospitals Writing Committee (2004) · Diabetes Care · doi:10.2337/diacare.27.2.553 · Cited by 1,266
Reversal of Lesions of Diabetic Nephropathy after Pancreas Transplantation
Fioretto, P., Steffes, M. W., Sutherland, D. E. R., Goetz, F. C., & Mauer, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807093390202 · Cited by 1,135
NEW-ONSET DIABETES AFTER TRANSPLANTATION: 2003 INTERNATIONAL CONSENSUS GUIDELINES1
Davidson, J., Wilkinson, A., Dantal, J., Dotta, F., Haller, H., Hernandez, D., Kasiske, B. L., Kiberd, B., Krentz, A., Legendre, C., et al. (2003) · Transplantation · doi:10.1097/01.tp.0000069952.49242.3e · Cited by 676
Umpierrez, G. E., Smiley, D., Zisman, A., Prieto, L. M., Palacio, A., Ceron, M., Puig, A., & Mejia, R. (2007) · Diabetes Care · doi:10.2337/dc07-0295 · Cited by 671
Montori, V. M., Basu, A., Erwin, P. J., Velosa, J. A., Gabriel, S. E., & Kudva, Y. C. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.583 · Cited by 528
Association, A. D. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.775 · Cited by 464
Relationship of Early Hyperglycemia to Mortality in Trauma Patients
Laird, A. M., Miller, P. R., Kilgo, P. D., Meredith, J. W., & Chang, M. C. (2004) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/01.ta.0000123267.39011.9f · Cited by 457
American College of Endocrinology Position Statement on Inpatient Diabetes and Metabolic Control
Garber, A. J., Moghissi, E. S., Bransome, E. D., Clark, N. G., Clement, S., Cobin, R. H., Furnary, A. P., Hirsch, I. B., Levy, P., Roberts, R., et al. (2004) · Endocrine Practice · doi:10.4158/ep.10.s2.4 · Cited by 409
Research works printed but not linked: 2
- [14]Chakkera H, Weil J, Khan A, Cook C, Mazur M, Mulligan D, Reddy S, Moss A, McKeel K, Heilman R: Early post-transplant hyperglycemia is predictive of the development of new onset diabetes mellitus in kidney transplant recipients [Abstract]. Am J Transplant 7[Suppl 2]: 462, 2007 [Google Scholar]
- [24]Joint Commission on Accreditation of Healthcare Organizations: Inpatient Diabetes Certification. Available at: http://www.jointcommission.org/CertificationPrograms/Inpatient+Diabetes/. Accessed February 7, 2007 [PubMed]
Cited by
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
“In most cases, such stress- or steroidinduced hyperglycemia resolves by the time of discharge (89,90).”
Background2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s002 · Cited by 3,116
2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s002 · Cited by 2,697
2. Classification and Diagnosis of Diabetes:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s002 · Cited by 2,433
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s002 · Cited by 2,086
2. Diagnosis and classification of diabetes: standards of care in diabetes-2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Ebekozien, O., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s002 · Cited by 1,393
Sharif, A., Hecking, M., de Vries, A. P. J., Porrini, E., Hornum, M., Rasoul-Rockenschaub, S., Berlakovich, G., Krebs, M., Kautzky-Willer, A., Schernthaner, G., et al. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12850 · Cited by 532
“Hyperglycemia is exceptionally common in the early posttransplant period, detectable in approximately 90% of kidney allograft recipients in the early fewweeks (12,13).”
Background2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s002 · Cited by 473
Halden, T. A. S., Kvitne, K. E., Midtvedt, K., Rajakumar, L., Robertsen, I., Brox, J., Bollerslev, J., Hartmann, A., Åsberg, A., & Jenssen, T. (2019) · Diabetes Care · doi:10.2337/dc19-0093 · Cited by 231
Early Basal Insulin Therapy Decreases New-Onset Diabetes after Renal Transplantation
Hecking, M., Haidinger, M., Döller, D., Werzowa, J., Tura, A., Zhang, J., Tekoglu, H., Pleiner, J., Wrba, T., Rasoul-Rockenschaub, S., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011080835 · Cited by 226
Novel views on new-onset diabetes after transplantation: development, prevention and treatment
Hecking, M., Werzowa, J., Haidinger, M., Horl, W. H., Pascual, J., Budde, K., Luan, F. L., Ojo, A., de Vries, A. P. J., Porrini, E., et al. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs583 · Cited by 120
Chakkera, H. A., Knowler, W. C., Devarapalli, Y., Weil, E. J., Heilman, R. L., Dueck, A., Mulligan, D. C., Reddy, K. S., Moss, A. A., Mekeel, K. L., et al. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09481209 · Cited by 105
Self-citationPost-transplantation diabetes—state of the art
Sharif, A., & Cohney, S. J. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00387-3 · Cited by 100
Genetics of New-Onset Diabetes after Transplantation
McCaughan, J. A., McKnight, A. J., & Maxwell, A. P. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013040383 · Cited by 86
Conte, C., & Secchi, A. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1137-8 · Cited by 81
Can New-Onset Diabetes After Kidney Transplant Be Prevented?
Chakkera, H. A., Weil, E. J., Pham, P.-T., Pomeroy, J., & Knowler, W. C. (2013) · Diabetes Care · doi:10.2337/dc12-2067 · Cited by 80
Self-citationNew-Onset Diabetes After Kidney Transplantation: Prevalence, Risk Factors, and Management
Sarno, G., Muscogiuri, G., & Rosa, P. D. (2012) · Transplantation · doi:10.1097/tp.0b013e31824db97d · Cited by 75
Eide, I. A., Halden, T. A. S., Hartmann, A., Åsberg, A., Dahle, D. O., Reisæter, A. V., & Jenssen, T. G. (2016) · Transplant International · doi:10.1111/tri.12757 · Cited by 68
Glucocorticoid-Induced Hyperglycemia: A Neglected Problem
Cho, J.-H., & Suh, S. (2024) · Endocrinology and Metabolism · doi:10.3803/enm.2024.1951 · Cited by 63
Post-Transplant Diabetes Mellitus and Prediabetes in Renal Transplant Recipients: An Update
Rodríguez‐Rodríguez, A. E., Porrini, E., Hornum, M., Donate‐Correa, J., Febles, R. M., Ramchand, S. K., Lima, M. X. M., & Torres, A. (2021) · The Nephron journals/Nephron journals · doi:10.1159/000514288 · Cited by 52
Karelis, A. D., Hébert, M., RABASA-LHORET, R. P. R., & Räkel, A. (2015) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2015.08.014 · Cited by 45
Langsford, D., & Dwyer, K. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i10.1132 · Cited by 44
Management Strategies for Posttransplant Diabetes Mellitus after Heart Transplantation: A Review
Cehic, M. G., Nundlall, N., Greenfield, J. R., & Macdonald, P. S. (2018) · Journal of Transplantation · doi:10.1155/2018/1025893 · Cited by 43
Schwaiger, E., Krenn, S., Kurnikowski, A., Bergfeld, L., Pérez‐Sáez, M. J., Frey, A., Topitz, D., Bergmann, M. M., Hödlmoser, S., Bachmann, F., et al. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021010127 · Cited by 43
Diabetes and Cardiovascular Risk in Renal Transplant Patients
Rysz, J., Franczyk, B., Radek, M., Ciałkowska-Rysz, A. D., & Gluba-Brzózka, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073422 · Cited by 42
Káposztás, Z., Gyürüs, É., & Kahan, B. D. (2011) · Transplantation Proceedings · doi:10.1016/j.transproceed.2011.04.008 · Cited by 41
Hyperglycemia and Diabetes Mellitus Following Organ Transplantation
Galindo, R. J., & Wallia, A. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0707-1 · Cited by 39
Algorithm, Human, or the Centaur: How to Enhance Clinical Care?Preprint
Dean, A., Orfanoudaki, A., Saghafian, S., Song, K., Chakkera, H. A., & Cook, C. B. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4302002 · Cited by 38
Self-citationAmbiguous Dynamic Treatment Regimes: A Reinforcement Learning Approach
Saghafian, S. (2023) · Management Science · doi:10.1287/mnsc.2022.00883 · Cited by 36
Guimarães, J., Araújo, A., dos Santos, F. P. P. V., Nunes, C. S., & Casal, M. C. (2015) · Transplantation Proceedings · doi:10.1016/j.transproceed.2015.03.008 · Cited by 35
Munshi, V. N., Saghafian, S., Cook, C. B., Werner, K. T., & Chakkera, H. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0226873 · Cited by 35
Self-citationData-Driven Management of Post-Transplant Medications: An APOMDP Approach
Boloori, A., Saghafian, S., Chakkera, H. A., & Cook, C. B. (2017) · Manufacturing & Service Operations Management · doi:10.1287/msom.2019.0797 · Cited by 35
Self-citationEarly Post-Renal Transplant Hyperglycemia
Iqbal, A., Zhou, K., Kashyap, S. R., & Lansang, M. C. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab697 · Cited by 32
Posttransplantation Diabetes Mellitus Among Solid Organ Recipients in a Danish Cohort
dos Santos, Q., Hornum, M., Terrones‐Campos, C., Crone, C. G., Wareham, N. E., Søborg, A., Rasmussen, A., Gustafsson, F., Perch, M., Soerensen, S. S., et al. (2022) · Transplant International · doi:10.3389/ti.2022.10352 · Cited by 32
Sitagliptin Might Be a Favorable Antiobesity Drug For New Onset Diabetes After a Renal Transplant
Soliman, A. R., Fathy, A., Khashab, S., Shaheen, N., & Soliman, M. A. (2013) · Experimental and Clinical Transplantation · doi:10.6002/ect.2013.0018 · Cited by 31
Jaszczuk, S., Natarajan, S., & Papalois, V. E. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11123435 · Cited by 30
Park, S.-C., Yoon, Y.-D., Jung, H., Kim, K.-H., Choi, J., Park, S.-H., Kim, C.-D., Kim, Y.-L., Kim, H.-K., Huh, S., et al. (2015) · Transplantation Proceedings · doi:10.1016/j.transproceed.2014.11.053 · Cited by 27
Evolution of Glycemic Control and Variability After Kidney Transplant
Aouad, L. J., Clayton, P. A., Wyburn, K., Gracey, D. M., & Chadban, S. J. (2018) · Transplantation · doi:10.1097/tp.0000000000002155 · Cited by 26
Hyperglycemia management in patients with posttransplantation diabetes
Galindo, R. J., Fried, M., Breen, T., & Tamler, R. (2016) · Endocrine Practice · doi:10.4158/ep151039.ra · Cited by 25
Characterization of Remitting and Relapsing Hyperglycemia in Post-Renal-Transplant Recipients
Boloori, A., Saghafian, S., Chakkera, H. A., & Cook, C. B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142363 · Cited by 25
Self-citationStevens, R. B., Lane, J. T., Boerner, B. P., Miles, C. D., Rigley, T. H., Sandoz, J. P., Nielsen, K. J., Skorupa, J. Y., Skorupa, A. J., Kaplan, B. E., et al. (2011) · Clinical Transplantation · doi:10.1111/j.1399-0012.2011.01425.x · Cited by 25
Role of sex in post-transplant diabetes mellitus development: Are men and women equal?
Dedinská, I., Graňák, K., Vnučák, M., Skálová, P., Kováčiková, L., Laca, Ľ., Miklušica, J., Prídavková, D., Galajda, P., & Mokáň, M. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.12.017 · Cited by 24
Diabetes mellitus in dialysis and renal transplantation
Ben-David, E., Hull, R., & Banerjee, D. (2021) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188211048663 · Cited by 23
Incidence, Risk Factors, and Trends for Postheart Transplantation Diabetes Mellitus
Munshi, V. N., Saghafian, S., Cook, C. B., Steidley, D. E., Hardaway, B., & Chakkera, H. A. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.10.054 · Cited by 22
Self-citationHepatic Glucocorticoid Receptor Action and Glucose Homeostasis
Chang, M., & Wang, J.-C. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf030 · Cited by 22
A randomized trial of continuous glucose monitoring to improve post‐transplant glycemic control
Jandovitz, N., George, S. J., Abate, M. T., Kressel, A. M., Bolognese, A. C., Lau, L., Nair, V. V., & Grodstein, E. I. (2023) · Clinical Transplantation · doi:10.1111/ctr.15139 · Cited by 20
Kidney Transplantation in Type 2 Diabetic Patients: A Matched Survival Analysis
Rocha, A., Malheiro, J., Martins, L. S., Fonseca, I. M., Dias, L., Pedroso, S., Almeida, M., & Henriques, A. C. (2013) · Transplantation Proceedings · doi:10.1016/j.transproceed.2012.11.013 · Cited by 20
Diabetes in Kidney Transplantation
Cantarin, M. P. M. (2021) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2021.10.004 · Cited by 19
Jin, H. Y., Lee, K. A., Kim, Y. J., Park, T. S., Lee, S., Park, S. K., Hwang, H. P., Yang, J. D., Ahn, S.-W., & Yu, H. C. (2019) · Journal of Diabetes Research · doi:10.1155/2019/1757182 · Cited by 19
Management of the Hospitalized Transplant Patient
Boerner, B. P., Shivaswamy, V., Goldner, W. S., & Larsen, J. L. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0585-6 · Cited by 18
New Onset Diabetes After Organ Transplantation: Risk Factors, Treatment, and Consequences
Popović, L., & Bulum, T. (2025) · Diagnostics · doi:10.3390/diagnostics15030284 · Cited by 17
Fonouni, H., Rad, M. T., Golriz, M., Faridar, A., Esmaeilzadeh, M., Jarahian, P., Hafezi, M., Jafarieh, S., Macher‐Goeppinger, S., Longerich, T., et al. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr308 · Cited by 17
New-onset Diabetes Mellitus After Kidney Transplantation—A Paired Kidney Analysis
Bzoma, B., Konopa, J., Chamienia, A. L., Lukiański, M., Kobiela, J., Śledziński, Z., & Dębska-Ślizień, A. M. (2018) · Transplantation Proceedings · doi:10.1016/j.transproceed.2018.02.119 · Cited by 17
Werzowa, J. M., Säemann, M. D., Mohl, A., Bergmann, M. M., Kaltenecker, C. C., Brozek, W., Thomas, A., Haidinger, M., Antlanger, M., Kovarik, J. J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193569 · Cited by 17
Hyperglycemia During the Immediate Period Following Liver Transplantation
Werner, K. T., Mackey, P., Castro, J. C., Carey, E. J., Chakkera, H. A., & Cook, C. B. (2016) · Future Science OA · doi:10.4155/fsoa-2015-0010 · Cited by 16
Self-citationThe Effect of Different Glycaemic States on Renal Transplant Outcomes
Sheu, A., Depczynski, B., O’Sullivan, A., Luxton, G., & Mangos, G. (2016) · Journal of Diabetes Research · doi:10.1155/2016/8735782 · Cited by 15
Pérez-Flores, I., Sánchez-Fructuoso, A. I., Calvo, N., Valga, F., & Barrientos, A. (2010) · Transplantation Proceedings · doi:10.1016/j.transproceed.2010.08.005 · Cited by 15
Diabetic Kidney Disease in Post-Transplant Diabetes Mellitus: Causes, Treatment and Outcomes
Lim, L., Chang, J., & Kuo, H. (2023) · Biomedicines · doi:10.3390/biomedicines11020470 · Cited by 14
The Diagnosis of Posttransplantation Diabetes Mellitus: Meeting the Challenges
Werzowa, J. M., Hecking, M., Haidinger, M., Döller, D., Sharif, A., Tura, A., & Säemann, M. D. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0601-x · Cited by 14
Claes, K. J., Bammens, B., Kuypers, D. R. J., Meijers, B. K. I., Naesens, M., Sprangers, B., Vanrenterghem, Y. F. C., Lerut, E., de Loor, H., & Evenepoel, P. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu219 · Cited by 13
Alfieri, C., Campioli, E., Fiorina, P., Orsi, E., Grancini, V., Regalia, A. L., Campise, M., Verdesca, S., Delfrate, N. W., Molinari, P., et al. (2024) · Nutrients · doi:10.3390/nu16101520 · Cited by 12
Klangjareonchai, T., Eguchi, N., Tantisattamo, E., Ferrey, A., Reddy, U. G., Dafoe, D. C., & Ichii, H. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13030413 · Cited by 12
Housawi, A. A., Abdulrahman, M., Idris, M. A., Elhakimi, W., Akhtar, M., Hammam, M., Aldajani, A. A., Aljamaan, Y. M., & Alshahri, H. (2018) · Saudi Journal of Kidney Diseases and Transplantation · doi:10.4103/1319-2442.239641 · Cited by 12
Wilcox, J., Waite, C., Tomlinson, L., Driscoll, J., Karim, A., Day, E., & Sharif, A. (2016) · Trials · doi:10.1186/s13063-016-1543-6 · Cited by 11
Diabetes in stiff-person syndrome
Heneberg, P. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.07.005 · Cited by 11
Osté, M. C. J., Flores-Guerrero, J. L., Gruppen, E. G., Kieneker, L. M., Connelly, M. A., Otvos, J. D., Dullaart, R. P. F., & Bakker, S. J. L. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020511 · Cited by 11
Bren, A., & Saghafian, S. (2019) · INFORMS Journal on Optimization · doi:10.1287/ijoo.2018.0007 · Cited by 11
Conte, C., Maggiore, U., Cappelli, G., Ietto, G., Lai, Q., Salis, P., Marchetti, P., Piemonti, L., Secchi, A., Capocasale, E., et al. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.05.004 · Cited by 10
Novel management of diabetes in kidney transplantation
Ong, S., & Rhee, C. M. (2021) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000665 · Cited by 10
Diabetic Kidney Disease in Post-Kidney Transplant Patients
Pham, N.-Y. T., Cruz, D., Marin, L. M., Ravender, R., & García, P. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13030793 · Cited by 9
Immunomodulation in post-transplant diabetes mellitus: Challenges and management
Maoz, H., & Elalouf, A. (2025) · Transplant Immunology · doi:10.1016/j.trim.2025.102304 · Cited by 9
Vega-Roman, C., Leal-Cortés, C. Á., Buen, E. P., Gómez-Navarro, B., Melo, Z., Franco-Acevedo, A., Medina‐Pérez, M., Jalomo‐Martínez, B., Martínez-Martínez, P., Evangelista‐Carrillo, L. A., et al. (2021) · Medicine · doi:10.1097/md.0000000000026595 · Cited by 8
Kuang, W., Raven, L. M., & Muir, C. A. (2024) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2024.2307011 · Cited by 7
Parekh, J. R., Roll, G. R., Wisel, S. A., Rushakoff, R. J., & Hirose, R. (2016) · Clinical Transplantation · doi:10.1111/ctr.12811 · Cited by 7
New Onset Diabetes After Transplantation (NODAT) — scientific data review
Zielińska, K., Kukulski, L., Wróbel, M. P., Przybyłowski, P., Zielińska, M., & Strojek, K. (2020) · Clinical Diabetology · doi:10.5603/dk.2020.0047 · Cited by 6
Orfanoudaki, A., Cook, C. B., Saghafian, S., Castro, J. C., Kosiorek, H., & Chakkera, H. A. (2023) · Clinical Transplantation · doi:10.1111/ctr.15177 · Cited by 6
Self-citationBzoma, B., Konopa, J., Chamienia, A. L., Kostro, J., & Dębska-Ślizień, A. M. (2025) · Medicine · doi:10.1097/md.0000000000043981 · Cited by 5
Kaplan, A., Manela, T., Hod, T., Ghinea, R., Mor, E., Tirosh, A., Tirosh, A., & Shlomai, G. (2024) · Clinics and Practice · doi:10.3390/clinpract14050156 · Cited by 5
Reducing hyperglycaemia post-kidney and liver transplant: a quality improvement initiative
Clemens, K. K., Brahmania, M., Weernink, C., Lotfy, K., Rjoob, H., Berberich, A. J., & Gob, A. (2022) · BMJ Open Quality · doi:10.1136/bmjoq-2021-001796 · Cited by 5
Iannino, N., Nasri, A., Räkel, A., Ducharme, A., Lachance, K., Racine, N., de Denus, S., Tremblay‐Gravel, M., Fortier, A., & White, M. (2018) · Journal of Transplantation · doi:10.1155/2018/9205083 · Cited by 5
Hyperglycemia among hospitalized cancer patients with coexisting diabetes mellitus
Karlin, N. J., Cheng, M., Castro, J. C., & Cook, C. B. (2015) · Diabetes Management · doi:10.2217/dmt.15.36 · Cited by 5
Self-citationQiu, M., Chen, S., Chen, J., & Gao, H. (2025) · Renal Failure · doi:10.1080/0886022x.2024.2444383 · Cited by 4
Is microdialysis useful for early detection of acute rejection after kidney transplantation?
Fonouni, H., Golriz, M., Majlesara, A., Faridar, A., Esmaeilzadeh, M., Jarahian, P., Rad, M. T., Hafezi, M., Garoussi, C., Macher‐Goeppinger, S., et al. (2015) · International Journal of Surgery · doi:10.1016/j.ijsu.2015.03.024 · Cited by 4
Sanyal, D., Biswas, M., & Chaudhari, N. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.11.019 · Cited by 4
Munshi, V. N., Saghafian, S., Cook, C. B., Aradhyula, S. V., & Chakkera, H. A. (2021) · Annals of Transplantation · doi:10.12659/aot.928624 · Cited by 4
Self-citationAcosta-Gualandri, A., Blydt‐Hansen, T. D., Islam, N., & Amed, S. (2021) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2021.05.004 · Cited by 4
Enhanced Recovery After Surgery (ERAS) in Renal Transplantation Patients
Karaaslan, P., & Yanaral, T. U. (2025) · Türk anesteziyoloji ve reanimasyon derneği dergisi · doi:10.4274/tjar.2024.241702 · Cited by 4
Odler, B., Huemer, M., Schwaiger, E., Borenich, A., Kurnikowski, A., Krall, M., Hafner-Gießauf, H., Eleftheriadis, G. K., Bachmann, F., Faura, A., et al. (2023) · Transplant International · doi:10.3389/ti.2023.11370 · Cited by 4
New Onset Diabetes After Transplant (NODAT)
Solhjoo, M., & Kumar, S. C. (2019) · StatPearls · Cited by 4
Post-Transplant Diabetes Mellitus
Bhattarai, M., & Bhayana, S. (2022) · Springer eBooks · doi:10.1007/978-3-031-13569-9_61 · Cited by 3
Pre, peri and posttransplant diabetes mellitus
Essawy, B. E., & KANDEEL, F. R. (2018) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000469 · Cited by 3
Post-transplantation diabetes mellitus: an overview
Sklyanik, I. A., Шамхалова, М. Ш., & Shestakova, M. V. (2015) · Diabetes Mellitus · doi:10.14341/dm2015220-31 · Cited by 3
Kurnikowski, A., Werzowa, J. M., Hödlmoser, S., Krenn, S., Paschen, C., Mußnig, S., Tura, A., Harreiter, J., Krebs, M., Song, P. X. ‐., et al. (2024) · Kidney Medicine · doi:10.1016/j.xkme.2024.100860 · Cited by 3
Fragoso, L. V. C., de Araújo, M. F. M., Lobo, L. F. D. S., Schreen, D., Zanetti, M. L., & Damasceno, M. M. C. (2022) · Einstein (São Paulo) · doi:10.31744/einstein_journal/2022ao6959 · Cited by 3
dos Santos, Q., Leung, P., Thorball, C., Ledergerber, B., Fellay, J., MacPherson, C. R., Hornum, M., Terrones‐Campos, C., Rasmussen, A., Gustafsson, F., et al. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1282412 · Cited by 2
Hyperglycemic Management After Solid Organ Transplantation
Rollins, J. L. (2012) · Critical Care Nursing Clinics of North America · doi:10.1016/j.ccell.2012.11.013 · Cited by 2
Medications affecting glycemic control
Korayem, G. B. (2017) · Integrative Clinical Medicine · doi:10.15761/icm.1000103 · Cited by 2
New-onset Diabetes after Renal Transplantation – A Clinical Insight
Sanyal, D. (2019) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_248_19 · Cited by 1
Metadata
- Authors
- Chakkera, H. A., Weil, E. J., Castro, J., Heilman, R. L., Reddy, K. S., Mazur, M. J., Hamawi, K., Mulligan, D. C., Moss, A. A., Mekeel, K. L., Cosio, F. G., & Cook, C. B.
- Affiliations
- Mayo Clinic (US)
- National Institutes of Health (US)
- ORCID
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2009-04
- Volume
- 4
- Issue
- 4
- Pages
- 853-859
- ISSN
- 1555-9041 (ISSN-L)
- PMC
- PMC2666437
- OpenAlex
- W2083842417
- Cited by
- 124
- References
- 27
- Citations by year
- 2026: 1 · 2025: 9 · 2024: 8 · 2023: 10 · 2022: 9 · 2021: 13 · 2020: 11 · 2019: 10 · 2018: 10 · 2017: 4 · 2016: 7 · 2015: 13 · 2014: 3 · 2013: 5 · 2012: 3
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Center for Research Resources (KL2RR024151)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- hyperglycemia, kidney transplantation, postoperative period, new-onset diabetes, insulin therapy, immunosuppression, hypoglycemia, short-acting insulin, long-acting insulin, hospitalization
- MeSH terms
- Adult, Blood Glucose, Female, Humans, Hyperglycemia, Hypoglycemic Agents, Inpatients, Insulin, Male, Middle Aged, Retrospective Studies, Risk Factors, Surgical Wound Infection, Time Factors, Prevalence, Kidney Transplantation, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.